Alyeska Investment Group
CLOV icon

Alyeska Investment Group’s Clover Health Investments CLOV Stock Holding History

Alyeska Investment Group’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,785,318
Closed -$29.9M – 746
2020
Q4 		$29.9M Buy
1,785,318
+1,089,675
+157% +$12.1M 0.42% 67
2020
Q3 		$8.67M Buy
695,643
+575,685
+480% +$6.37M 0.13% 196
2020
Q2 		$1.34M Buy
+119,958
New +$1.29M 0.02% 384

Other funds holding CLOV

GCP
Greenoaks Capital Partners Orinda, California $2.36B AUM 17.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
SIG
Senator Investment Group New York $2.74B AUM 55.95% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return

Alyeska Investment Group's CLOV Position: Q1 2021 in Review

Alyeska Investment Group sold out of Clover Health Investments (CLOV) in Q1 2021, closing a stake of 1,785,318 shares — an estimated $29.9M sold.

Alyeska Investment Group first reported a position in CLOV in Q2 2020 and held it in 3 quarters. The position peaked at $29.9M in Q4 2020. 138 funds tracked by Wall St. Rank hold CLOV as of Q1 2021.

  • Alyeska Investment Group reported no remaining Clover Health Investments position as of Q1 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 1,785,318 Clover Health Investments shares in Q1 2021, an estimated $29.9M.
  • Alyeska Investment Group first reported a position in Clover Health Investments in Q2 2020 and held it in 3 quarters.
  • Alyeska Investment Group's Clover Health Investments position peaked at $29.9M in Q4 2020.
  • 138 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2021.

Based on Alyeska Investment Group's 13F filing for Q1 2021, filed 17 May 2021.